Detrimental effects of chemotherapeutics and other drugs on the endothelium: A call for endothelial toxicity profiling

Pharmacological Reports : PR
Tomasz WojcikStefan Chlopicki

Abstract

The vascular endothelium is a real "maestro of circulation", and endothelial dysfunction leads to atherothrombosis, its cardiovascular complications, as well as to many other diseases. It is surprising that quite a large number of drugs seem to hamper the vasoprotective mechanisms of the endothelium, possibly promoting the development of cardiovascular diseases in patients initially treated for non-cardiological conditions. Toxicity profiling (including cardiac and liver toxicity assessment) is a routine procedure performed during pre-clinical drug development. Unfortunately, endothelium-dependent side effects are not taken into account in standard toxicity profiling protocols, as the "endothelial safety" of drugs is not required in order to enter the clinical phase of drug development. Presumably, this might be one of the reasons why several efficient therapeutics, including rofecoxib (COX-2 inhibitor), torcetrapib (CETP-inhibitor), and bardoxolone (Nrf2 activator), have unexpectedly displayed clinically significant cardiovascular hazard, resulting in their withdrawal from the market or alarming comments, respectively. In this review, we will briefly characterize the endothelial activity profiles of chemotherapeutics, antidepr...Continue Reading

References

Jan 1, 1987·Cancer Chemotherapy and Pharmacology·B L SamuelsB J Kennedy
Oct 1, 1995·Trends in Biochemical Sciences·E C Friedberg
Sep 15, 1996·The American Journal of Cardiology·J C BarefootR B Williams
Feb 5, 1998·JAMA : the Journal of the American Medical Association·S P RooseI Gergel
Nov 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C L ShapiroI C Henderson
Jan 15, 1999·General Pharmacology·G WeissV R Gordeuk
Jul 27, 1999·British Journal of Clinical Pharmacology·J M VilaS Lluch
Sep 27, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·P Stenvinkel
Nov 27, 2001·Science·D CortezS J Elledge
Jun 4, 2002·Nature Reviews. Molecular Cell Biology·James C Wang
Aug 7, 2002·Circulation·Julian P J HalcoxArshed A Quyyumi
Nov 7, 2002·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·M MorgantiR Giardino
Mar 11, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J NuverJ A Gietema
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Aug 24, 2004·Current Pharmaceutical Design·Pal Pacher, Valeria Kecskemeti
Oct 8, 2004·The New England Journal of Medicine·Garret A Fitzgerald
Dec 4, 2004·International Journal of Geriatric Psychiatry·Robert C Baldwin
Mar 15, 2005·Endothelium : Journal of Endothelial Cell Research·Varsha KaushalPaulette Mehta
Jul 13, 2005·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·C P SerraF C Braga
Aug 16, 2005·Journal of the American College of Cardiology·Andrew SherwoodJames A Blumenthal
Dec 13, 2005·Biochimica Et Biophysica Acta·Matthew B Wolf, John W Baynes
Aug 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Melinda L TelliAlice E Guardino
Dec 15, 2007·Nature Reviews. Drug Discovery·Andrew Bullen
Dec 22, 2007·Human Psychopharmacology·Paul Mackin
Mar 15, 2008·Cancer·David J VaughnEmile R Mohler
Jan 16, 2010·Journal of Cardiovascular Pharmacology·Steven C WoodBelay Tesfamariam
Feb 11, 2011·British Journal of Pharmacology·Hg LavertyJp Valentin
Jul 9, 2011·The Oncologist·Chetan ShenoyGretchen G Kimmick
Oct 11, 2011·Cancer Treatment Reviews·Aspasia SoultatiChristos Papadimitriou
Oct 30, 2012·Nature Medicine·Sui ZhangEdward T H Yeh

❮ Previous
Next ❯

Citations

Sep 1, 2015·Pharmacological Reports : PR·Stefan Chlopicki
Jul 4, 2016·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Ewelina SzafraniecMalgorzata Baranska
May 18, 2016·British Journal of Pharmacology·Andreas DaiberThomas Münzel
Nov 29, 2017·Oxidative Medicine and Cellular Longevity·Donato CappettaKonrad Urbanek
Aug 14, 2019·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Irina ElchevaVladimir S Spiegelman
Apr 7, 2021·Journal of Medicinal Chemistry·Adriana AdamczykMalgorzata Baranska
Jul 3, 2021·Cancers·Tamara Mc ErlainCristina M Branco
Jul 14, 2021·Bone Marrow Transplantation·Thomas LuftAleksandar Radujkovic

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Kathmandu University Medical Journal (KUMJ)
P Mishra, S Palaian
Pharmacological Reports : PR
Anna BarStefan Chlopicki
Pharmacoepidemiology and Drug Safety
Félix M Arellano
Journal of Postgraduate Medicine
V D Rajadhyaksha, S A Dahanukar
© 2021 Meta ULC. All rights reserved